Israel-based technology holding company Elron joins venture firms Accelmed and Access Medical Ventures, and Peregrine Ventures backing the Israel-based cartilage treatment company.

Alchemia acquired Audeo in 2006, when it was known as Meditech Research, paying $16.9m in shares plus a $2m loan.

Biolex filed for chapter 7 on July 3, according to news provider Triangle Business Journal. Investors had invested $190m in Biolex since it was founded in 1997, Triangle Business Journal said.

Genkyotex was joined in the series C round extension by private equity firmEdmond de Rothschild Investment Partners, venture firm Vesalius Biocapital Partners, and incubator Eclosion.

UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.

The corporate venturing unit of GlaxoSmithKline joins Imperial Innovations, Invesco Perpetual and Lundbeckfond Ventures backing the UK-based cancer treatment company.

The University of Washington's venture fund is set to deploy the money during four years.

The biopharmaceutical company which is a spin-out from the University of Bath relocates to the North-East of England.

The healthcare company backed by Celgene and Eli Lilly's corporate venturing unit files to list on Nasdaq.